Creo Medical Group (CREO) Competitors GBX 18 +0.25 (+1.41%) (As of 11/8/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades CREO vs. EKF, NCYT, IUG, POLX, BELL, IHC, AVO, RUA, MHC, and SUNShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include EKF Diagnostics (EKF), Novacyt (NCYT), Intelligent Ultrasound Group (IUG), Polarean Imaging (POLX), Belluscura (BELL), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), and Surgical Innovations Group (SUN). These companies are all part of the "medical devices" industry. Creo Medical Group vs. EKF Diagnostics Novacyt Intelligent Ultrasound Group Polarean Imaging Belluscura Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MyHealthChecked Surgical Innovations Group Creo Medical Group (LON:CREO) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends. Do institutionals & insiders believe in CREO or EKF? 56.1% of Creo Medical Group shares are owned by institutional investors. Comparatively, 70.3% of EKF Diagnostics shares are owned by institutional investors. 22.4% of Creo Medical Group shares are owned by company insiders. Comparatively, 5.2% of EKF Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is CREO or EKF more profitable? EKF Diagnostics has a net margin of 9.37% compared to Creo Medical Group's net margin of -73.93%. EKF Diagnostics' return on equity of 7.58% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets Creo Medical Group-73.93% -38.49% -20.09% EKF Diagnostics 9.37%7.58%5.27% Does the media prefer CREO or EKF? In the previous week, Creo Medical Group had 1 more articles in the media than EKF Diagnostics. MarketBeat recorded 1 mentions for Creo Medical Group and 0 mentions for EKF Diagnostics. EKF Diagnostics' average media sentiment score of 0.00 beat Creo Medical Group's score of -1.05 indicating that EKF Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Creo Medical Group Negative EKF Diagnostics Neutral Which has higher earnings and valuation, CREO or EKF? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreo Medical Group£30.30M2.15-£22.40M-£0.06-300.00EKF Diagnostics£50.95M2.46£4.78M£0.012,765.00 Does the MarketBeat Community favor CREO or EKF? EKF Diagnostics received 221 more outperform votes than Creo Medical Group when rated by MarketBeat users. Likewise, 76.76% of users gave EKF Diagnostics an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote. CompanyUnderperformOutperformCreo Medical GroupOutperform Votes10667.52% Underperform Votes5132.48% EKF DiagnosticsOutperform Votes32776.76% Underperform Votes9923.24% Which has more volatility and risk, CREO or EKF? Creo Medical Group has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, EKF Diagnostics has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. SummaryEKF Diagnostics beats Creo Medical Group on 12 of the 15 factors compared between the two stocks. Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£65.12M£2.11B£5.39B£1.58BDividend YieldN/A2.49%4.61%11.03%P/E Ratio-300.00210.54111.961,668.58Price / Sales2.15205.811,289.62232,151.23Price / Cash2.4316.0539.1436.61Price / Book1.383.416.043.09Net Income-£22.40M£70.94M£118.88M£142.59M7 Day Performance-7.82%-0.11%5.08%20.90%1 Month Performance-19.46%-1.59%11.07%18.11%1 Year Performance-46.67%23.35%45.44%30.54% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 18+1.4%N/A-48.6%£65.12M£30.30M-300.00279Negative NewsHigh Trading VolumeEKFEKF DiagnosticsN/AGBX 26.80-1.8%N/A-2.1%£121.60M£50.95M2,680.00356NCYTNovacytN/AGBX 54.40-0.4%N/A-5.0%£38.42M£18.56M-104.62120IUGIntelligent Ultrasound GroupN/AGBX 11.15-3.0%N/A+14.0%£36.47M£9.88M-1,115.0065Gap UpPOLXPolarean ImagingN/AGBX 1.59+3.9%N/A-79.2%£19.18M£1.87M-79.2528BELLBelluscuraN/AGBX 10.68+1.7%N/A-62.2%£17.99M£1.80M-106.8024IHCInspiration Healthcare GroupN/AGBX 17.25-1.4%N/A-59.3%£15.47M£34.30M-123.21224Gap UpAVOAdvanced OncotherapyN/AGBX 1.75-9.1%N/A+0.0%£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.10-3.5%N/A-12.7%£6.89M£2.19M-277.5048MHCMyHealthCheckedN/AGBX 12.23-4.1%N/A+22.0%£6.36M£9.39M-611.2516News CoverageGap DownSUNSurgical Innovations GroupN/AGBX 0.50-8.7%N/A-39.7%£4.68M£12.54M-21.1180Gap Down Related Companies and Tools Related Companies EKF Diagnostics Competitors Novacyt Competitors Intelligent Ultrasound Group Competitors Polarean Imaging Competitors Belluscura Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors MyHealthChecked Competitors Surgical Innovations Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:CREO) was last updated on 11/9/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.